Editorial

Chemistry is still cool
April 7, 2015

Looking for new customers in France, Belgium, United Kingdom, and other European countries, I realized that the number of pharmaceutical companies…

Read More
Outrageous
Outrageous
March 31, 2015

Copper-Catalyzed Selective Arylations of Benzoxazoles with Aryl Iodides Still trying to decide if this is a joke or not. Any help…

Read More
Who had come in first ?
February 19, 2015

Being French, living in Spain and working in English I read different news items from different countries in several languages. Recently,…

Read More
Superposed Binding Pose
Beware the Binding Pose
February 12, 2015

One of my favourites blogs, which I have mentioned in previous posts, is In the Pipeline, written by Derek Lowe. He…

Read More
Cancer, Bad Luck and Press Releases…
January 26, 2015

Everything started with a headline: “Most cancers are caused by bad luck – not bad judgement, says study” (Independent), and another:…

Read More
2014 in Numbers
January 19, 2015

As is our tradition, here you have our figures about projects and products of 2014. Compiling this info takes only a…

Read More
Are cars becoming more innovative than drugs?
December 12, 2014

For the first time in 10 years there is no pharmaceutical company among the three biggest R&D spenders! According to the…

Read More
Lorcaserin approved
June 29, 2012

Well, it is the first anti-obesity drug approved by the FDA in 13 years (last one was Roche’s Orlistat, marketed as Xenical…

Read More
GalChimiApplus
December 1, 2011

During the last CPhI in Frankfurt we officially presented our joint venture with Applus+ LGAI, christening it GalChimiApplus. This collaboration will…

Read More
Number crunching
October 1, 2011

The review selected for this issue is in fact what the J. Med. Chem. calls a ‘Perspective’ paper. To summarize, it…

Read More